Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel vs Liposomal Doxorubicin in Advanced AIDS-KS
NCT00003350Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 1999
- Primary completion
- Mar 2007
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in Kaposi sarcoma (KS), sponsored by National Cancer Institute. Started Mar 1999; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT00003350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003350.